Martin Scherzer

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: LIFE SCIENCE ALLIANCE. 2022;5(5):e202101244
Recruitment of Scc2/4 to double-strand breaks depends on γH2A and DNA end resection
Scherzer M; Giordano F; Ferran MS; Strom L
Article: NATURE COMMUNICATIONS. 2020;11(1):3704
Therapeutic paradigm of dual targeting VEGF and PDGF for effectively treating FGF-2 off-target tumors
Hosaka K; Yang Y; Seki T; Du Q; Jing X; He X; Wu J; Zhang Y; Morikawa H; Nakamura M; Scherzer M; Sun X; Xu Y; Cheng T; Li X; Liu X; Li Q; Liu Y; Hong A; Chen Y; Cao Y
Article: SCIENTIFIC REPORTS. 2018;8(1):1151
Exclusion from spheroid formation identifies loss of essential cell-cell adhesion molecules in colon cancer cells
Stadler M; Scherzer M; Walter S; Holzner S; Pudelko K; Riedl A; Unger C; Kramer N; Weil B; Neesen J; Hengstschlaeer M; Dolznig H
Article: CELL DISCOVERY. 2018;4:3
Dual roles of endothelial FGF-2-FGFR1-PDGF-BB and perivascular FGF-2-FGFR2-PDGFRβ signaling pathways in tumor vascular remodeling
Hosaka K; Yang Y; Nakamura M; Andersson P; Yang X; Zhang Y; Seki T; Scherzer M; Dubey O; Wang X; Cao Y
Article: ONCOGENE. 2017;36(39):5460-5472
Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression
Kramer N; Schmoellerl J; Unger C; Nivarthi H; Rudisch A; Unterleuthner D; Scherzer M; Riedl A; Artaker M; Crncec I; Lenhardt D; Schwarz T; Prieler B; Han X; Hengstschaelger M; Schueler J; Eferl R; Moriggl R; Sommergruber W; Dolznig H
Article: ONCOGENE. 2017;36(38):5341-5355
Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms
Unger C; Kramer N; Unterleuthner D; Scherzer M; Burian A; Rudisch A; Stadler M; Schlederer M; Lenhardt D; Riedl A; Walter S; Wernitznig A; Kenner L; Hengstschlger M; Schler J; Sommergruber W; Dolznig H
Article: ONCOGENE. 2015;34(7):815-825
IGFBP7, a novel tumor stroma marker, with growth-promoting effects in colon cancer through a paracrine tumor-stroma interaction.
Rupp C; Scherzer M; Rudisch A; Unger C; Haslinger C; Schweifer N; Artaker M; Nivarthi H; Moriggl R; Hengstschläger M; Kerjaschki D; Sommergruber W; Dolznig H; Garin-Chesa P
Article: JOURNAL OF BIOMOLECULAR SCREENING. 2014;19(7):1047-1059
The Resazurin Reduction Assay Can Distinguish Cytotoxic from Cytostatic Compounds in Spheroid Screening Assays.
Walzl A; Unger C; Kramer N; Unterleuthner D; Scherzer M; Hengstschläger M; Schwanzer-Pfeiffer D; Dolznig H

Alla övriga publikationer

Doctoral thesis: 2022
Towards a cohesive understanding of the DNA damage response as a therapeutic target
Scherzer M
Review: SEMINARS IN CANCER BIOLOGY. 2015;35:107-124
Increased complexity in carcinomas: Analyzing and modeling the interaction of human cancer cells with their microenvironment.
Stadler M; Walter S; Walzl A; Kramer N; Unger C; Scherzer M; Unterleuthner D; Hengstschläger M; Krupitza G; Dolznig H
Review: ADVANCED DRUG DELIVERY REVIEWS. 2014;79-80:50-67
Modeling human carcinomas: physiologically relevant 3D models to improve anti-cancer drug development.
Unger C; Kramer N; Walzl A; Scherzer M; Hengstschläger M; Dolznig H

Anställningar

Anknuten till Forskning, Medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2025-2027

Examina och utbildning

Medicine Doktorsexamen, Institutionen för cell- och molekylärbiologi, Karolinska Institutet, 2022

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI